Categories: Company News

iLife introduces gene test for breast cancer risk

New Delhi, May 28, 2015:

Genetics and genomics company iLife Discoveries has introduced a new gene test in India to evaluate breast cancer recurrence risks.

The test, MammaPrint & Blueprint, is able to analyse molecular sub-types of the cancer, risk of recurrence of early stage cancer, thereby enabling medical oncologists to take informed decisions on the course of treatment, a company release said.

Addressing a press conference here on Wednesday, Anand Gupta, Founder & CMD, iLife Discoveries, said: “Not all patients need to go through the difficult and challenging chemotherapy after a surgical procedure… However, in the absence of reliable mechanisms to provide efficient insight into the cancer and the possibility of its recurrence, most oncologists take recourse to the tried and tested chemotherapy mechanism.” He claimed this test can help doctors reduce the use of unnecessary chemotherapy.

Ramesh Sarin, Senior Consultant, Surgical Oncology, Indraprastha Apollo Hospitals, Delhi, said: “Until now, we did not have any test to distinguish women in which cancer would spread from the women in whom it would not. But now, we have an FDA approved 70 gene Mammaprint test, by which we can predict the behaviour of tumour by looking at its genomic profiling and manage the patient accordingly.” Business Line

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

9 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

9 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

1 day ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

2 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago